Utility of immunophenotyping of plasma cells in multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Utility of immunophenotyping of plasma cells in multiple myeloma

Published:2015-10-28 Issue:2 Volume:57 Page:252-253
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Gertz Morie A.,Buadi Francis K.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1068310

Reference21 articles.

1. CD20-positive multiple myeloma: can conventional chemotherapy still be used to achieve ideal outcome for these patients?

2. Is CD20 positive plasma cell myeloma a unique clinicopathological entity? A study of 40 cases and review of the literature

3. Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

4. Characterization of clonogenic multiple myeloma cells

5. CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Cell Dyscrasias;Tata Memorial Centre Textbook of Oncology;2024

2. Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders;Indian Journal of Hematology and Blood Transfusion;2017-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3